ScholarLens Back to search
2021•Journal of Thoracic OncologyOpen access

P76.70 Afatinib After Progression on Osimertinib in Patients with EGFR-Mutated Lung Adenocarcinoma

Jacqueline V. Aredo, Heather A. Wakelee, Joel W. Neal, Sukhmani Kaur Padda

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Osimertinib, Afatinib, Medicine, T790M, Cetuximab, Lung cancer, Oncology, Adenocarcinoma

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
P76.70 Afatinib After Progression on Osimertinib in Patients with EGFR-Mutated Lung Adenocarcinoma — Research Paper | ScholarLens